InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the detailed record of transactions filed by Strange Kevin T. Director active across 1 company, notably Inari Medical, Inc.. Aggregated, 4 disclosures have been published. History available since 1 October 2024. The latest transaction was disclosed on 4 February 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Strange Kevin T is a declarant with 4 filings in total. The 4 sampled filings relate to Inari Medical, Inc., where he is Chief Financial Officer, between 2024-10-03 and 2025-02-19. The modal transaction nature is Attribution, and buy and sell volumes are both 0 EUR across this recent sample, with one filing of 3090.623697328759 EUR on 2025-01-03.